NCT01502280 (BALANCE).
Study name | Fluorescence‐guided surgery for low‐ and high‐grade gliomas |
Methods | Randomised. Single‐blind |
Participants | Newly diagnosed glioma (HGG and LGG) |
Interventions | 5‐ALA (Gliolan) vs placebo (ascorbic acid) |
Outcomes | Volume of residual disease; overall survival; and 6‐month progression‐free survival |
Starting date | November 2010 |
Contact information | Nader Sanai (principal investigator), Norissa Honea (overall contact) |
Notes | Barrow, Phoenix, AZ, USA |